Cannabis Suisse Corp Stock Net Asset
| CSUI Stock | USD 0.01 0.01 90.48% |
As of the 12th of February 2026, Cannabis Suisse shows the Downside Deviation of 48.75, mean deviation of 16.54, and Risk Adjusted Performance of 0.1019. Cannabis Suisse Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cannabis Suisse's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cannabis Suisse's valuation are provided below:Cannabis Suisse Corp does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Cannabis |
Cannabis Suisse 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cannabis Suisse's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cannabis Suisse.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Cannabis Suisse on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Cannabis Suisse Corp or generate 0.0% return on investment in Cannabis Suisse over 90 days. Cannabis Suisse is related to or competes with Next Generation. Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreationa... More
Cannabis Suisse Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cannabis Suisse's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cannabis Suisse Corp upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 48.75 | |||
| Information Ratio | 0.1113 | |||
| Maximum Drawdown | 295.56 | |||
| Value At Risk | (48.74) | |||
| Potential Upside | 50.0 |
Cannabis Suisse Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannabis Suisse's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cannabis Suisse's standard deviation. In reality, there are many statistical measures that can use Cannabis Suisse historical prices to predict the future Cannabis Suisse's volatility.| Risk Adjusted Performance | 0.1019 | |||
| Jensen Alpha | 3.41 | |||
| Total Risk Alpha | 0.9788 | |||
| Sortino Ratio | 0.0858 | |||
| Treynor Ratio | 0.3562 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cannabis Suisse's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cannabis Suisse February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1019 | |||
| Market Risk Adjusted Performance | 0.3662 | |||
| Mean Deviation | 16.54 | |||
| Semi Deviation | 16.59 | |||
| Downside Deviation | 48.75 | |||
| Coefficient Of Variation | 881.83 | |||
| Standard Deviation | 37.61 | |||
| Variance | 1414.71 | |||
| Information Ratio | 0.1113 | |||
| Jensen Alpha | 3.41 | |||
| Total Risk Alpha | 0.9788 | |||
| Sortino Ratio | 0.0858 | |||
| Treynor Ratio | 0.3562 | |||
| Maximum Drawdown | 295.56 | |||
| Value At Risk | (48.74) | |||
| Potential Upside | 50.0 | |||
| Downside Variance | 2376.83 | |||
| Semi Variance | 275.28 | |||
| Expected Short fall | (55.54) | |||
| Skewness | 3.96 | |||
| Kurtosis | 23.9 |
Cannabis Suisse Corp Backtested Returns
Cannabis Suisse is out of control given 3 months investment horizon. Cannabis Suisse Corp secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We are able to break down and analyze data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 4.27% are justified by taking the suggested risk. Use Cannabis Suisse Risk Adjusted Performance of 0.1019, downside deviation of 48.75, and Mean Deviation of 16.54 to evaluate company specific risk that cannot be diversified away. Cannabis Suisse holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 11.95, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cannabis Suisse will likely underperform. Use Cannabis Suisse treynor ratio, as well as the relationship between the semi variance and rate of daily change , to analyze future returns on Cannabis Suisse.
Auto-correlation | 0.08 |
Virtually no predictability
Cannabis Suisse Corp has virtually no predictability. Overlapping area represents the amount of predictability between Cannabis Suisse time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cannabis Suisse Corp price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Cannabis Suisse price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Cannabis Suisse Corp has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Cannabis Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cannabis Suisse's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Cannabis Suisse could also be used in its relative valuation, which is a method of valuing Cannabis Suisse by comparing valuation metrics of similar companies.Cannabis Suisse is currently under evaluation in net asset category among its peers.
Cannabis Fundamentals
| Return On Asset | -3.08 | |||
| Operating Margin | (25.44) % | |||
| Current Valuation | 3.37 M | |||
| Shares Outstanding | 40.65 M | |||
| Shares Owned By Insiders | 30.50 % | |||
| Price To Sales | 732.00 X | |||
| Revenue | 7.77 K | |||
| Gross Profit | 6.04 K | |||
| EBITDA | (122.31 K) | |||
| Net Income | (187.89 K) | |||
| Cash And Equivalents | 5 | |||
| Total Debt | 102.73 K | |||
| Debt To Equity | 273.30 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (32.09 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -3.76 | |||
| Market Capitalization | 1.34 M | |||
| Z Score | 7.8 |
About Cannabis Suisse Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cannabis Suisse Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabis Suisse using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabis Suisse Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Cannabis Pink Sheet
Cannabis Suisse financial ratios help investors to determine whether Cannabis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannabis with respect to the benefits of owning Cannabis Suisse security.